$69.81
-0.63[-0.89%]
At close: Jun 7
$69.81
0[0.00%]
After Hours: 5:38PM EDT
Latest News for Centene Stock (NYSE:CNC)
Centene Stock (NYSE: CNC)
Categories: All
Monday, June 03, 2024
Friday, May 31, 2024
Thursday, May 30, 2024
Wednesday, May 29, 2024
- Centene Expects To Reaffirm FY24 Adjusted EPS Guidance Of Greater Than $6.80, Est $6.85Benzinga Newsdesk
- Why UnitedHealth Stock Is Sliding WednesdayVaishali Prayag
- Shares of health insurers are trading lower in sympathy with UnitedHealth, which fell after comments at the Bernstein 40th Annual Strategic Decisions Conference.Benzinga Newsdesk
- Here's How Much You Would Have Made Owning Centene Stock In The Last 15 YearsBenzinga Insights
Tuesday, May 14, 2024
Monday, May 06, 2024
Friday, May 03, 2024
Thursday, May 02, 2024
- 10 Analysts Assess Centene: What You Need To KnowBenzinga Insights
- Barclays Maintains Overweight on Centene, Raises Price Target to $104Benzinga Newsdesk
- Wellcare, The Medicare Business Of Centene Corp And Wellvana Announce Partnership To Expand Patient-Centered Primary Care For Benefit Of Medicare Advantage Members In Georgia, Tennessee And TexasBenzinga Newsdesk
Tuesday, April 30, 2024
Monday, April 29, 2024
Friday, April 26, 2024
- Centene's First-Quarter Surge: Sales Soar To $40.41B, Exceeding Expectations: What's Next For The Healthcare Company?Vandana Singh
- Centene shares are trading higher after the company reported better-than-expected Q1 2024 adjusted EPS and sales. Additionally, the company raised upbeat its guidance for 2024.Benzinga Newsdesk
- Centene Expects 2024 Revenue Guidance Of $147.5B-$150.5B Versus Consensus Of $146.14B, Including Premium And Service Revenues Of $135.5B-$138.5B Versus Prior Guidance Of $134.5B-$137.5BBenzinga Newsdesk
- Centene Revises Its 2024 Adjusted EPS Guidance Floor Of Greater Than $6.80 Versus Prior Guidance Of Greater Than $6.70 Versus Consensus Of $6.78Benzinga Newsdesk
- Centene Reports Q1 Health Benefits Ratio Of 87.1%, With Membership Of 28,422,800Benzinga Newsdesk
- Centene Q1 2024 Adj EPS $2.26 Beats $2.08 Estimate, Sales $40.407B Beat $36.536B EstimateBenzinga Newsdesk
Wednesday, April 24, 2024
Monday, April 22, 2024
Tuesday, April 16, 2024
Monday, April 15, 2024
- See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, MolinaVandana Singh
- Evaluating Centene: Insights From 7 Financial AnalystsBenzinga Insights
- Centene shares are trading higher after Florida announced Statewide Medicaid Managed Care Program awards, under which the company secured a statewide contract.Benzinga Newsdesk
- Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For MondayAvi Kapoor
- Wells Fargo Maintains Overweight on Centene, Raises Price Target to $93Benzinga Newsdesk
Thursday, April 11, 2024
Monday, April 08, 2024
Thursday, April 04, 2024
Tuesday, April 02, 2024
- Benzinga Opening Bell Update: Tesla Falls On Delivery Numbers, Oil Gains On Middle East Tensions, Healthcare Providers Drop On Medicare Advantage RatesBenzinga Newsdesk
- Shares of healthcare providers are trading lower after the CMS finalized payment updates for the 2025 Medicare Advantage and Medicare Part D programs.Benzinga Newsdesk
Monday, April 01, 2024
- Shares of several healthcare providers are trading lower after the CMS finalized payment updates for the 2025 Medicare Advantage and Medicare Part D programs.Benzinga Newsdesk
- CMS Says Under 2025 Rate Announcement, Payments From Gov. To MA Plans Are Expected To Increase On Average By 3.70%, From 2024; Federal Government Is Projected To Pay Between $500B-$600B In Medicare Advantage Payments To Private Health Plans In 2025Benzinga Newsdesk
- CMS Finalizes Payment Updates For 2025 Medicare Advantage And Medicare Part D ProgramsBenzinga Newsdesk